George A - Search Results

1

Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin.

George A, Marziniak M, Schäfers M, Toyka KV, Sommer C. George A, et al. Pain. 2000 Dec 1;88(3):267-275. doi: 10.1016/S0304-3959(00)00333-X. Pain. 2000. PMID: 11068114

2

Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein.

George A, Buehl A, Sommer C. George A, et al. Neurosci Lett. 2004 Dec 6;372(3):215-9. doi: 10.1016/j.neulet.2004.09.075. Neurosci Lett. 2004. PMID: 15542243

3

A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy.

Sommer C, Schmidt C, George A, Toyka KV. Sommer C, et al. Among authors: george a. Neurosci Lett. 1997 Nov 14;237(1):45-8. doi: 10.1016/s0304-3940(97)00813-6. Neurosci Lett. 1997. PMID: 9406876

4

Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1.

Sommer C, Schmidt C, George A. Sommer C, et al. Among authors: george a. Exp Neurol. 1998 May;151(1):138-42. doi: 10.1006/exnr.1998.6797. Exp Neurol. 1998. PMID: 9582261

5

Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury.

George A, Schmidt C, Weishaupt A, Toyka KV, Sommer C. George A, et al. Exp Neurol. 1999 Nov;160(1):124-32. doi: 10.1006/exnr.1999.7193. Exp Neurol. 1999. PMID: 10630197

6

Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve.

George A, Buehl A, Sommer C. George A, et al. Exp Neurol. 2005 Mar;192(1):163-6. doi: 10.1016/j.expneurol.2004.11.002. Exp Neurol. 2005. PMID: 15698630

7

Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerve is associated with a depletion of endoneurial interleukin-10 protein.

George A, Kleinschnitz C, Zelenka M, Brinkhoff J, Stoll G, Sommer C. George A, et al. Exp Neurol. 2004 Jul;188(1):187-91. doi: 10.1016/j.expneurol.2004.02.011. Exp Neurol. 2004. PMID: 15191815

8

Musculoskeletal pain in patients with myotonic dystrophy type 2.

George A, Schneider-Gold C, Zier S, Reiners K, Sommer C. George A, et al. Arch Neurol. 2004 Dec;61(12):1938-42. doi: 10.1001/archneur.61.12.1938. Arch Neurol. 2004. PMID: 15596616

9

[Musculoskeletal pain as the most prominent feature in myotonic dystrophy type 2].

George A, Schneider-Gold C, Reiners K, Sommer C. George A, et al. Schmerz. 2006 Sep;20(5):388, 390-4, 396-7. doi: 10.1007/s00482-006-0482-7. Schmerz. 2006. PMID: 16758212 German.

10

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.

Schneider-Gold C, Beck M, Wessig C, George A, Kele H, Reiners K, Toyka KV. Schneider-Gold C, et al. Among authors: george a. Neurology. 2003 Feb 11;60(3):500-2. doi: 10.1212/01.wnl.0000044405.29988.e1. Neurology. 2003. PMID: 12578937 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,955 results

Search Page

Filters